Left ventricular noncompaction is characterized by deep trabeculations in the LV endocardium in association with left ventricular hypertrophy, dilation or hypertrophy/dilation. Noncompaction of the ...

A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of—and repair ...

Loss-of-function in epicardial proteins called Numb Family Proteins, leads to left ventricular noncompaction, or spongy heart, presenting ...

University of Houston pharmacologist Mingfu Wu has been awarded $2.5 million from the National Heart, Lung, and Blood Institute to explore the cause of and therapeutic treatment for left ventricular ...

Non-compaction cardiomyopathy is a heart condition caused by defects that arise during fetal development and can have diverse health impacts in affected individuals, including sudden cardiac death.

Having explored how the heart is formed in utero, a University of Houston pharmacology researcher is reporting how cells and molecules act during that early formation and what might cause the heart ...

SAN FRANCISCO — The Heart Rhythm Society (HRS) has released their first-ever set of comprehensive recommendations on the diagnosis and treatment of arrhythmogenic cardiomyopathy. In this consensus ...

A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of - and repair ...